SEC Form 4 · accession 0001209191-17-007342
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James J Vaughn
Officer — Chief Commercial Officer
Period of report
Jan 31, 2017
Accepted (ET)
Feb 2, 2017 · 8:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 31, 2017 | A | 7,840 | $0.00 | A | 33,919 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) HoldingF3 | $27.48 | Jan 31, 2017 | A | 54,080 | A | — | Jan 31, 2027 | Common Stock | 54,080 | 54,080 | D |
Explanation of responses
- F1Restricted stock units awarded on January 31, 2017 which vest as to 1/3 of the shares on each of February 15, 2018, 2019 and 2020.
- F2Includes an aggregate of 18,280 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- F3The option becomes exercisable as to 25% of the shares on January 31, 2018, and becomes exercisable as to 1/48th of the shares each full month thereafter.